Table of Content

1 Amantadine HCl Oral Market Overview
1.1 Product Overview and Scope of Amantadine HCl Oral
1.2 Amantadine HCl Oral Segment by Type
1.2.1 Global Amantadine HCl Oral Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Capsules
1.2.4 Syrup
1.3 Amantadine HCl Oral Segment by Application
1.3.1 Global Amantadine HCl Oral Market Value by Application: (2024-2034)
1.3.2 Parkinson's Disease
1.3.3 Influenza
1.4 Global Amantadine HCl Oral Market Size Estimates and Forecasts
1.4.1 Global Amantadine HCl Oral Revenue 2018-2029
1.4.2 Global Amantadine HCl Oral Sales 2018-2029
1.4.3 Global Amantadine HCl Oral Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Amantadine HCl Oral Market Competition by Manufacturers
2.1 Global Amantadine HCl Oral Sales Market Share by Manufacturers (2018-2024)
2.2 Global Amantadine HCl Oral Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Amantadine HCl Oral Average Price by Manufacturers (2018-2024)
2.4 Global Amantadine HCl Oral Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Amantadine HCl Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amantadine HCl Oral, Product Type & Application
2.7 Amantadine HCl Oral Market Competitive Situation and Trends
2.7.1 Amantadine HCl Oral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amantadine HCl Oral Players Market Share by Revenue
2.7.3 Global Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amantadine HCl Oral Retrospective Market Scenario by Region
3.1 Global Amantadine HCl Oral Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amantadine HCl Oral Global Amantadine HCl Oral Sales by Region: 2018-2029
3.2.1 Global Amantadine HCl Oral Sales by Region: 2018-2024
3.2.2 Global Amantadine HCl Oral Sales by Region: 2024-2029
3.3 Global Amantadine HCl Oral Global Amantadine HCl Oral Revenue by Region: 2018-2029
3.3.1 Global Amantadine HCl Oral Revenue by Region: 2018-2024
3.3.2 Global Amantadine HCl Oral Revenue by Region: 2024-2029
3.4 North America Amantadine HCl Oral Market Facts & Figures by Country
3.4.1 North America Amantadine HCl Oral Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amantadine HCl Oral Sales by Country (2018-2029)
3.4.3 North America Amantadine HCl Oral Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amantadine HCl Oral Market Facts & Figures by Country
3.5.1 Europe Amantadine HCl Oral Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amantadine HCl Oral Sales by Country (2018-2029)
3.5.3 Europe Amantadine HCl Oral Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amantadine HCl Oral Market Facts & Figures by Country
3.6.1 Asia Pacific Amantadine HCl Oral Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amantadine HCl Oral Sales by Country (2018-2029)
3.6.3 Asia Pacific Amantadine HCl Oral Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amantadine HCl Oral Market Facts & Figures by Country
3.7.1 Latin America Amantadine HCl Oral Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amantadine HCl Oral Sales by Country (2018-2029)
3.7.3 Latin America Amantadine HCl Oral Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amantadine HCl Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Amantadine HCl Oral Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amantadine HCl Oral Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amantadine HCl Oral Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amantadine HCl Oral Sales by Type (2018-2029)
4.1.1 Global Amantadine HCl Oral Sales by Type (2018-2024)
4.1.2 Global Amantadine HCl Oral Sales by Type (2024-2029)
4.1.3 Global Amantadine HCl Oral Sales Market Share by Type (2018-2029)
4.2 Global Amantadine HCl Oral Revenue by Type (2018-2029)
4.2.1 Global Amantadine HCl Oral Revenue by Type (2018-2024)
4.2.2 Global Amantadine HCl Oral Revenue by Type (2024-2029)
4.2.3 Global Amantadine HCl Oral Revenue Market Share by Type (2018-2029)
4.3 Global Amantadine HCl Oral Price by Type (2018-2029)
5 Segment by Application
5.1 Global Amantadine HCl Oral Sales by Application (2018-2029)
5.1.1 Global Amantadine HCl Oral Sales by Application (2018-2024)
5.1.2 Global Amantadine HCl Oral Sales by Application (2024-2029)
5.1.3 Global Amantadine HCl Oral Sales Market Share by Application (2018-2029)
5.2 Global Amantadine HCl Oral Revenue by Application (2018-2029)
5.2.1 Global Amantadine HCl Oral Revenue by Application (2018-2024)
5.2.2 Global Amantadine HCl Oral Revenue by Application (2024-2029)
5.2.3 Global Amantadine HCl Oral Revenue Market Share by Application (2018-2029)
5.3 Global Amantadine HCl Oral Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zydus Pharmaceuticals
6.1.1 Zydus Pharmaceuticals Corporation Information
6.1.2 Zydus Pharmaceuticals Description and Business Overview
6.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.1.5 Zydus Pharmaceuticals Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Mylan Amantadine HCl Oral Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Teva Amantadine HCl Oral Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Vertical Pharmaceuticals
6.4.1 Vertical Pharmaceuticals Corporation Information
6.4.2 Vertical Pharmaceuticals Description and Business Overview
6.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.4.5 Vertical Pharmaceuticals Recent Developments/Updates
6.5 Adamas Pharmaceuticals
6.5.1 Adamas Pharmaceuticals Corporation Information
6.5.2 Adamas Pharmaceuticals Description and Business Overview
6.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.5.5 Adamas Pharmaceuticals Recent Developments/Updates
6.6 Upsher-Smith
6.6.1 Upsher-Smith Corporation Information
6.6.2 Upsher-Smith Description and Business Overview
6.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Upsher-Smith Amantadine HCl Oral Product Portfolio
6.6.5 Upsher-Smith Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sandoz Amantadine HCl Oral Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Mikart Pharmaceuticals
6.8.1 Mikart Pharmaceuticals Corporation Information
6.8.2 Mikart Pharmaceuticals Description and Business Overview
6.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.8.5 Mikart Pharmaceuticals Recent Developments/Updates
6.9 Pharmaceutical Associates, Inc. (PAI)
6.9.1 Pharmaceutical Associates, Inc. (PAI) Corporation Information
6.9.2 Pharmaceutical Associates, Inc. (PAI) Description and Business Overview
6.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Portfolio
6.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates
6.10 Wockhardt Bio AG
6.10.1 Wockhardt Bio AG Corporation Information
6.10.2 Wockhardt Bio AG Description and Business Overview
6.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Wockhardt Bio AG Amantadine HCl Oral Product Portfolio
6.10.5 Wockhardt Bio AG Recent Developments/Updates
6.11 CMP Pharma
6.11.1 CMP Pharma Corporation Information
6.11.2 CMP Pharma Amantadine HCl Oral Description and Business Overview
6.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.11.4 CMP Pharma Amantadine HCl Oral Product Portfolio
6.11.5 CMP Pharma Recent Developments/Updates
6.12 Bionpharma
6.12.1 Bionpharma Corporation Information
6.12.2 Bionpharma Amantadine HCl Oral Description and Business Overview
6.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Bionpharma Amantadine HCl Oral Product Portfolio
6.12.5 Bionpharma Recent Developments/Updates
6.13 Graviti Pharma
6.13.1 Graviti Pharma Corporation Information
6.13.2 Graviti Pharma Amantadine HCl Oral Description and Business Overview
6.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Graviti Pharma Amantadine HCl Oral Product Portfolio
6.13.5 Graviti Pharma Recent Developments/Updates
6.14 Alembic Pharmaceuticals
6.14.1 Alembic Pharmaceuticals Corporation Information
6.14.2 Alembic Pharmaceuticals Amantadine HCl Oral Description and Business Overview
6.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Alembic Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.14.5 Alembic Pharmaceuticals Recent Developments/Updates
6.15 Strides Pharma
6.15.1 Strides Pharma Corporation Information
6.15.2 Strides Pharma Amantadine HCl Oral Description and Business Overview
6.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Strides Pharma Amantadine HCl Oral Product Portfolio
6.15.5 Strides Pharma Recent Developments/Updates
6.16 Heritage Pharmaceuticals
6.16.1 Heritage Pharmaceuticals Corporation Information
6.16.2 Heritage Pharmaceuticals Amantadine HCl Oral Description and Business Overview
6.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Heritage Pharmaceuticals Amantadine HCl Oral Product Portfolio
6.16.5 Heritage Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amantadine HCl Oral Industry Chain Analysis
7.2 Amantadine HCl Oral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amantadine HCl Oral Production Mode & Process
7.4 Amantadine HCl Oral Sales and Marketing
7.4.1 Amantadine HCl Oral Sales Channels
7.4.2 Amantadine HCl Oral Distributors
7.5 Amantadine HCl Oral Customers
8 Amantadine HCl Oral Market Dynamics
8.1 Amantadine HCl Oral Industry Trends
8.2 Amantadine HCl Oral Market Drivers
8.3 Amantadine HCl Oral Market Challenges
8.4 Amantadine HCl Oral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Amantadine HCl Oral Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Amantadine HCl Oral Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Amantadine HCl Oral Market Competitive Situation by Manufacturers in 2022
Table 4. Global Amantadine HCl Oral Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Amantadine HCl Oral Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Amantadine HCl Oral Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Amantadine HCl Oral Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Amantadine HCl Oral Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Amantadine HCl Oral, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Amantadine HCl Oral, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amantadine HCl Oral, Product Type & Application
Table 12. Global Key Manufacturers of Amantadine HCl Oral, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amantadine HCl Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amantadine HCl Oral as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amantadine HCl Oral Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Amantadine HCl Oral Sales by Region (2018-2024) & (K Units)
Table 18. Global Amantadine HCl Oral Sales Market Share by Region (2018-2024)
Table 19. Global Amantadine HCl Oral Sales by Region (2024-2029) & (K Units)
Table 20. Global Amantadine HCl Oral Sales Market Share by Region (2024-2029)
Table 21. Global Amantadine HCl Oral Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Amantadine HCl Oral Revenue Market Share by Region (2018-2024)
Table 23. Global Amantadine HCl Oral Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Amantadine HCl Oral Revenue Market Share by Region (2024-2029)
Table 25. North America Amantadine HCl Oral Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Amantadine HCl Oral Sales by Country (2018-2024) & (K Units)
Table 27. North America Amantadine HCl Oral Sales by Country (2024-2029) & (K Units)
Table 28. North America Amantadine HCl Oral Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Amantadine HCl Oral Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Amantadine HCl Oral Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Amantadine HCl Oral Sales by Country (2018-2024) & (K Units)
Table 32. Europe Amantadine HCl Oral Sales by Country (2024-2029) & (K Units)
Table 33. Europe Amantadine HCl Oral Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Amantadine HCl Oral Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Amantadine HCl Oral Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Amantadine HCl Oral Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Amantadine HCl Oral Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Amantadine HCl Oral Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Amantadine HCl Oral Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Amantadine HCl Oral Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Amantadine HCl Oral Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Amantadine HCl Oral Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Amantadine HCl Oral Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Amantadine HCl Oral Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Amantadine HCl Oral Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Amantadine HCl Oral Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Amantadine HCl Oral Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Amantadine HCl Oral Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Amantadine HCl Oral Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Amantadine HCl Oral Sales (K Units) by Type (2018-2024)
Table 51. Global Amantadine HCl Oral Sales (K Units) by Type (2024-2029)
Table 52. Global Amantadine HCl Oral Sales Market Share by Type (2018-2024)
Table 53. Global Amantadine HCl Oral Sales Market Share by Type (2024-2029)
Table 54. Global Amantadine HCl Oral Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Amantadine HCl Oral Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Amantadine HCl Oral Revenue Market Share by Type (2018-2024)
Table 57. Global Amantadine HCl Oral Revenue Market Share by Type (2024-2029)
Table 58. Global Amantadine HCl Oral Price (USD/Unit) by Type (2018-2024)
Table 59. Global Amantadine HCl Oral Price (USD/Unit) by Type (2024-2029)
Table 60. Global Amantadine HCl Oral Sales (K Units) by Application (2018-2024)
Table 61. Global Amantadine HCl Oral Sales (K Units) by Application (2024-2029)
Table 62. Global Amantadine HCl Oral Sales Market Share by Application (2018-2024)
Table 63. Global Amantadine HCl Oral Sales Market Share by Application (2024-2029)
Table 64. Global Amantadine HCl Oral Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Amantadine HCl Oral Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Amantadine HCl Oral Revenue Market Share by Application (2018-2024)
Table 67. Global Amantadine HCl Oral Revenue Market Share by Application (2024-2029)
Table 68. Global Amantadine HCl Oral Price (USD/Unit) by Application (2018-2024)
Table 69. Global Amantadine HCl Oral Price (USD/Unit) by Application (2024-2029)
Table 70. Zydus Pharmaceuticals Corporation Information
Table 71. Zydus Pharmaceuticals Description and Business Overview
Table 72. Zydus Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Zydus Pharmaceuticals Amantadine HCl Oral Product
Table 74. Zydus Pharmaceuticals Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Mylan Amantadine HCl Oral Product
Table 79. Mylan Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Teva Amantadine HCl Oral Product
Table 84. Teva Recent Developments/Updates
Table 85. Vertical Pharmaceuticals Corporation Information
Table 86. Vertical Pharmaceuticals Description and Business Overview
Table 87. Vertical Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Vertical Pharmaceuticals Amantadine HCl Oral Product
Table 89. Vertical Pharmaceuticals Recent Developments/Updates
Table 90. Adamas Pharmaceuticals Corporation Information
Table 91. Adamas Pharmaceuticals Description and Business Overview
Table 92. Adamas Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Adamas Pharmaceuticals Amantadine HCl Oral Product
Table 94. Adamas Pharmaceuticals Recent Developments/Updates
Table 95. Upsher-Smith Corporation Information
Table 96. Upsher-Smith Description and Business Overview
Table 97. Upsher-Smith Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Upsher-Smith Amantadine HCl Oral Product
Table 99. Upsher-Smith Recent Developments/Updates
Table 100. Sandoz Corporation Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Sandoz Amantadine HCl Oral Product
Table 104. Sandoz Recent Developments/Updates
Table 105. Mikart Pharmaceuticals Corporation Information
Table 106. Mikart Pharmaceuticals Description and Business Overview
Table 107. Mikart Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Mikart Pharmaceuticals Amantadine HCl Oral Product
Table 109. Mikart Pharmaceuticals Recent Developments/Updates
Table 110. Pharmaceutical Associates, Inc. (PAI) Corporation Information
Table 111. Pharmaceutical Associates, Inc. (PAI) Description and Business Overview
Table 112. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product
Table 114. Pharmaceutical Associates, Inc. (PAI) Recent Developments/Updates
Table 115. Wockhardt Bio AG Corporation Information
Table 116. Wockhardt Bio AG Description and Business Overview
Table 117. Wockhardt Bio AG Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Wockhardt Bio AG Amantadine HCl Oral Product
Table 119. Wockhardt Bio AG Recent Developments/Updates
Table 120. CMP Pharma Corporation Information
Table 121. CMP Pharma Description and Business Overview
Table 122. CMP Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. CMP Pharma Amantadine HCl Oral Product
Table 124. CMP Pharma Recent Developments/Updates
Table 125. Bionpharma Corporation Information
Table 126. Bionpharma Description and Business Overview
Table 127. Bionpharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Bionpharma Amantadine HCl Oral Product
Table 129. Bionpharma Recent Developments/Updates
Table 130. Graviti Pharma Corporation Information
Table 131. Graviti Pharma Description and Business Overview
Table 132. Graviti Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Graviti Pharma Amantadine HCl Oral Product
Table 134. Graviti Pharma Recent Developments/Updates
Table 135. Alembic Pharmaceuticals Corporation Information
Table 136. Alembic Pharmaceuticals Description and Business Overview
Table 137. Alembic Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Alembic Pharmaceuticals Amantadine HCl Oral Product
Table 139. Alembic Pharmaceuticals Recent Developments/Updates
Table 140. Strides Pharma Corporation Information
Table 141. Strides Pharma Description and Business Overview
Table 142. Strides Pharma Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Strides Pharma Amantadine HCl Oral Product
Table 144. Strides Pharma Recent Developments/Updates
Table 145. Heritage Pharmaceuticals Corporation Information
Table 146. Heritage Pharmaceuticals Description and Business Overview
Table 147. Heritage Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Heritage Pharmaceuticals Amantadine HCl Oral Product
Table 149. Heritage Pharmaceuticals Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Amantadine HCl Oral Distributors List
Table 153. Amantadine HCl Oral Customers List
Table 154. Amantadine HCl Oral Market Trends
Table 155. Amantadine HCl Oral Market Drivers
Table 156. Amantadine HCl Oral Market Challenges
Table 157. Amantadine HCl Oral Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amantadine HCl Oral
Figure 2. Global Amantadine HCl Oral Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Amantadine HCl Oral Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Capsules Product Picture
Figure 6. Syrup Product Picture
Figure 7. Global Amantadine HCl Oral Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Amantadine HCl Oral Market Share by Application in 2022 & 2029
Figure 9. Parkinson's Disease
Figure 10. Influenza
Figure 11. Global Amantadine HCl Oral Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Amantadine HCl Oral Market Size (2018-2029) & (US$ Million)
Figure 13. Global Amantadine HCl Oral Sales (2018-2029) & (K Units)
Figure 14. Global Amantadine HCl Oral Average Price (USD/Unit) & (2018-2029)
Figure 15. Amantadine HCl Oral Report Years Considered
Figure 16. Amantadine HCl Oral Sales Share by Manufacturers in 2022
Figure 17. Global Amantadine HCl Oral Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Amantadine HCl Oral Players: Market Share by Revenue in 2022
Figure 19. Amantadine HCl Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Amantadine HCl Oral Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Amantadine HCl Oral Sales Market Share by Country (2018-2029)
Figure 22. North America Amantadine HCl Oral Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Amantadine HCl Oral Sales Market Share by Country (2018-2029)
Figure 26. Europe Amantadine HCl Oral Revenue Market Share by Country (2018-2029)
Figure 27. Germany Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Amantadine HCl Oral Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Amantadine HCl Oral Revenue Market Share by Region (2018-2029)
Figure 34. China Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Amantadine HCl Oral Sales Market Share by Country (2018-2029)
Figure 45. Latin America Amantadine HCl Oral Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Amantadine HCl Oral Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Amantadine HCl Oral Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Amantadine HCl Oral Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Amantadine HCl Oral by Type (2018-2029)
Figure 55. Global Revenue Market Share of Amantadine HCl Oral by Type (2018-2029)
Figure 56. Global Amantadine HCl Oral Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Amantadine HCl Oral by Application (2018-2029)
Figure 58. Global Revenue Market Share of Amantadine HCl Oral by Application (2018-2029)
Figure 59. Global Amantadine HCl Oral Price (USD/Unit) by Application (2018-2029)
Figure 60. Amantadine HCl Oral Value Chain
Figure 61. Amantadine HCl Oral Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed